Fetal echocardiography and a detailed non‐cardiovascular ultrasound examination were
performed prospectively between 14 and 23 weeks of gestation prior to genetic …

Se realiza una revisión bibliográfica de los síndromes genéticos que se asocian a defectos
cardíacos por ser las cardiopatías congénitas causa frecuente de mortalidad neonatal y …

This article describes the individual sonographic markers used in the Genetic Sonogram
Scoring Index. The importance of the clustering of markers forms the basis of the scoring …

Fetal nuchal thickening in the second trimester is suggested as an ultrasonographic sign
strongly suggesting the presence of Down syndrome. To better understand this potentially …

Objectives To examine the relationship between the measurement of nuchal translucency in
the first trimester and nuchal fold in the second trimester in normal pregnancy. Methods This …

The most effective first-trimester Down syndrome screening protocol in current use employs
three independent markers: maternal serum levels of PAPP-A and free βhCG, and …

Objective To compare the efficacy of fetal nuchal translucency screening, maternal serum
screening and combined screening for Down syndrome. Design A prospective study. Setting …

Objectives The purpose of this study was to determine factors that influence the detection
rate of sonographic markers of fetal aneuploidy (SMFA). Methods We reviewed the …

OBJECTIVE:: To determine whether measurements of the iliac wing angle on sonograms of
the second-trimester fetus can be used to detect fetuses at increased risk for Down …